Home » Topics » BioWorld Science

BioWorld Science
RSS

Immunic presents new preclinical and clinical data for IMU-935

July 13, 2021

Qixleef phase II protocol modifications approved

July 13, 2021

Prokineticin-2 as therapeutic target for prevention of neuronal death

July 13, 2021

Aptorum reports further interim phase I data on ALS-4

July 13, 2021

Identification of antivirulence compound ANT-3273 for P. aeruginosa infection

July 13, 2021

Dosing begins in phase I study of CB-010 in B-cell NHL

July 13, 2021

First patient treated in phase I study of INKmune in high-risk MDS

July 13, 2021

Hummingbird and MD Anderson collaborate to advance VISTA antagonist antibody, HMBD-002

July 13, 2021

EscharEx debridement agent demonstrates efficiency, safety in chronic wound study

July 13, 2021

ALG2-CDG model in zebrafish displays human phenotypes and hypo-N-glycosylation

July 13, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...